Accordingly, analysis of the IRS of LGR5 also revealed that LGR5 expression is significantly increased from normal cervix to cervical cancer in situ and finally to cervical cancers (p<0.01, Fig. 1C). The gene discussed is LGR5; the disease is cervical carcinoma.